Microbio Statistics

Total Valuation

Microbio has a market cap or net worth of TWD 14.03 billion. The enterprise value is 13.48 billion.

Market Cap	14.03B
Enterprise Value	13.48B

Important Dates

The last earnings date was Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

Microbio has 588.17 million shares outstanding. The number of shares has increased by 0.36% in one year.

Current Share Class	588.17M
Shares Outstanding	588.17M
Shares Change (YoY)	+0.36%
Shares Change (QoQ)	+0.98%
Owned by Insiders (%)	0.08%
Owned by Institutions (%)	7.47%
Float	428.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.94
PB Ratio	1.25
P/TBV Ratio	1.47
P/FCF Ratio	20.23
P/OCF Ratio	19.34
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-12.14
EV / Sales	7.63
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	19.44

Financial Position

The company has a current ratio of 6.50, with a Debt / Equity ratio of 0.05.

Current Ratio	6.50
Quick Ratio	5.95
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	0.82
Interest Coverage	-42.64

Financial Efficiency

Return on equity (ROE) is -10.50% and return on invested capital (ROIC) is -2.16%.

Return on Equity (ROE)	-10.50%
Return on Assets (ROA)	-2.01%
Return on Invested Capital (ROIC)	-2.16%
Return on Capital Employed (ROCE)	-3.47%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.13
Inventory Turnover	5.15

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.51% in the last 52 weeks. The beta is 1.30, so Microbio's price volatility has been higher than the market average.

Beta (5Y)	1.30
52-Week Price Change	-39.51%
50-Day Moving Average	26.28
200-Day Moving Average	34.51
Relative Strength Index (RSI)	47.51
Average Volume (20 Days)	1,165,187

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Microbio had revenue of TWD 1.77 billion and -1.11 billion in losses. Loss per share was -1.88.

Revenue	1.77B
Gross Profit	692.61M
Operating Income	-442.64M
Pretax Income	-1.28B
Net Income	-1.11B
EBITDA	-338.60M
EBIT	-442.64M
Loss Per Share	-1.88

Full Income Statement

Balance Sheet

The company has 2.69 billion in cash and 569.55 million in debt, giving a net cash position of 2.12 billion or 3.60 per share.

Cash & Cash Equivalents	2.69B
Total Debt	569.55M
Net Cash	2.12B
Net Cash Per Share	3.60
Equity (Book Value)	11.26B
Book Value Per Share	16.32
Working Capital	2.57B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 725.51 million and capital expenditures -31.99 million, giving a free cash flow of 693.53 million.

Operating Cash Flow	725.51M
Capital Expenditures	-31.99M
Free Cash Flow	693.53M
FCF Per Share	1.18

Full Cash Flow Statement

Margins

Gross margin is 39.20%, with operating and profit margins of -25.05% and -62.84%.

Gross Margin	39.20%
Operating Margin	-25.05%
Pretax Margin	-72.57%
Profit Margin	-62.84%
EBITDA Margin	-19.16%
EBIT Margin	-25.05%
FCF Margin	39.25%

Dividends & Yields

Microbio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.36%
Shareholder Yield	-0.36%
Earnings Yield	-7.91%
FCF Yield	4.94%

Dividend Details

Stock Splits

The last stock split was on August 29, 2024. It was a forward split with a ratio of 1.049999998.

Last Split Date	Aug 29, 2024
Split Type	Forward
Split Ratio	1.049999998

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a